APGE Apogee Therapeutics Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: APGE

Price (delayed)

$134.45

Market cap

$10.18B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.34

Enterprise value

$10.08B

?
Relative Growth: Rel. Growth: 4
Relative Strength: Rel. Strength: 97
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 7
Highlights
The debt has decreased by 37% YoY and by 15% from the previous quarter
APGE's equity has surged by 93% year-on-year but it is down by 4.9% since the previous quarter
The quick ratio has soared by 62% YoY but it has contracted by 19% from the previous quarter
APGE's net income is down by 24% year-on-year and by 7% since the previous quarter
The company's EPS fell by 5% YoY
Sector: Healthcare
Industry: Biotechnology
Website: https://www.apogeetherapeutics.com
Peers: AMGN GILD VRTX REGN

Key stats

What are the main financial stats of APGE

APGE stock price

How has the Apogee Therapeutics stock price performed over time
Intraday
-0.07%
1 week
-0.03%
1 month
0.47%
1 year
259.88%
YTD
78.13%
QTD
1.3%

Financial performance

How have Apogee Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$328.11M
Net income
-$294.37M
Gross margin
N/A
Net margin
N/A
APGE's net income is down by 24% year-on-year and by 7% since the previous quarter
Apogee Therapeutics's operating income has decreased by 21% YoY and by 7% QoQ

Price vs fundamentals

How does APGE's price correlate with its fundamentals

Growth

What is Apogee Therapeutics's growth rate over time

Valuation

What is Apogee Therapeutics stock price valuation
P/E
N/A
P/B
8.48
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS fell by 5% YoY
APGE's equity has surged by 93% year-on-year but it is down by 4.9% since the previous quarter
APGE's P/B is 49% above its last 4 quarters average of 5.7

Efficiency

How efficient is Apogee Therapeutics business performance
The company's return on invested capital rose by 15% QoQ and by 13% YoY
APGE's return on equity is up by 14% year-on-year and by 8% since the previous quarter
Apogee Therapeutics's ROA has increased by 14% YoY and by 10% from the previous quarter

Dividends

What is APGE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APGE.

Financial health

How did Apogee Therapeutics financials performed over time
APGE's total assets has surged by 103% year-on-year and by 3.3% since the previous quarter
The current ratio has surged by 62% year-on-year but it has declined by 19% since the previous quarter
The debt is 99% less than the equity
APGE's equity has surged by 93% year-on-year but it is down by 4.9% since the previous quarter
APGE's debt to equity has plunged by 50% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.